Amsterdam Report, English
Amsterdam, 22-24 March 2000
"Tuberculosis and Sustainable Development"
Amsterdam Declaration to Stop TB World TBDay
- Ministerial Conference for twenty of the worlds highest TBburden countries
- Amsterdam Declaration to Stop TB adopted on Friday 24 March 2000
- WORLD TB DAY24 March: "Forging New Partnerships to Stop TB"
- AConference co-hosted by the Ministry of Health, Welfare and Sport and the Ministry of
Development Cooperation of the Netherlands; organized by the World Health Organization and
the World Bank
Agenda
Opening Ceremony
19:30-20:00
- Welcoming Remarks:Dr Gro Harlem Brundtland, Director-General, World Health Organization
- Statement: Ms Eveline Herfkens, Minister for Development Cooperation, the Netherlands
- Session 1. Improving Health:A Catalyst for Development
08:45-08:50
- Opening of Session, Ms Clare Short, Session Chair, Secretary of State for International
Development, UK
08:50-09:00
- "TB Control: A Dynamic Process in a Low Burden Country" Dr Els Borst-Eilers,
Minister of Health, Welfare and Sport, the Netherlands
09:00-09:10
- "Meeting the Threat of TB: The Case of New York City" Dr Donna Shalala,
Secretary, Department of Health and Human Services, USA
09:10-09:15
- Video: "Tuberculosis and Sustainable Development"
09:15-09:25
- "Tuberculosis Control: Why it Makes Development Sense" Ms Mieko Nishimizu,
Vice-President, The World Bank
09:25-09:30
- Closing of Session, Ms Clare Short, Session Chair
- Session 2. Confronting and Overcoming Challenges
10:00
- Opening of Session, Dr David Heymann, Session Chair, Executive Director, WHO Programme
on Communicable Diseases
10:05-10:15
- "TB, HIV/AIDS and the Global Response", Dr Peter Piot, Executive Director,
UNAIDS
10:15-10:20
- Video: "Tuberculosis and HIV/AIDSThe dual epidemic"
10:20-11:45
- Ministerial PanelConfronting and Overcoming Challenges
- Presentations: Bangladesh, Kenya, United Republic of Tanzania, Viet Nam followed by
Plenary Discussion
11:45-12:00
- Closing of Session, Dr David Heymann, Session Chair
- Session 3. Taking Action
13:30
- Opening of Session, Dr Ernest Loevinsohn, Session Chair, Director
General, Canadian International Development Agency (CIDA)
13:35-13:45
- Opportunities for Action, Dr Arata Kochi, Director, Stop TB Initiative,
WHO
13:45-13:55
- Personal Testimony on TB, Mr Ram Khadka, Katmandu, Nepal
13:55-14:00
- Video: "Serving the Poor: Primary Health Care and TB Control in
Peru"
14:00-14:45
- Preparation SessionConference Declaration, H.E. Korn Dabbaransi,
Declaration, Session Chair, Minister of Public Health, Thailand
14:45-14:50
- Closing of Session, Dr Ernest Loevinsohn, Session Chair
11:30-12:00
- Adoption Session: "Amsterdam Declaration to Stop TB"
- H.E. Korn Dabbaransi, Declaration Session Chair,Deputy Prime Minister and Minister of
Public Health, Thailand
- Session 4. Concurrent Round Tables
15:00-16:00
- Concurrent Round TablesFirst Round
- Round tables were open to all Conference participants and consisted of short country
presentations followed by facilitated group discussions
- Finance Track "Socioeconomic impacts of TB and TB/HIV"
Session Chair: Dr Peter Piot, Executive Director, UNAIDS
Presentations: India, Indonesia, Uganda, Zimbabwe
- Health Track "TB and Health Systems Development"
Session Chair: Ms Satu Hassi, Minister for Environment & Development Cooperation,
Finland
Presentations: Cambodia, China, Ethiopia, Philippines, Viet Nam
16:30-17:30
- Concurrent Round TablesSecond Round
- Finance Track "Options for Financing and Sustainability"
Session Chair: Dr David Nabarro, Project Manager, Roll Back Malaria, WHO
Presentations: Congo DR, Pakistan, Philippines, Russian Federation
- Health Track "Strategies to Cope with the Dual Epidemic"
Session Chair: Dr Uton Muchtar Rafei, Regional Director, SEARO, WHO
Presentations: South Africa, Thailand, Uganda, Zimbabwe
17:3018:30
- Declaration Drafting Group
- (Incorporating Contributions from Ministerial Round Table Rapporteurs)
- Session 5. Investing in Health for the Long-Term
08:45
Opening of Session:Ms Mieko Nishimizu, Vice-President, The World Bank, Session Co-chair
08:50-09:30
- Presentation of Round Table Summaries
- Rapporteurs from Concurrent Round Tables held on Thursday, 23 March
09:30-09:40
- "TB and Sustainable DevelopmentLessons from Other Health Programs"
- Dr William H. Foege, Senior Health Adviser, Bill and Melinda Gates Foundation
09:40-10:50
- Ministerial Panel: "Financing and Sustainability"
- Presentations: Brazil, China, India, Nigeria followed by Plenary Discussion
10:50-11:00
- Closing of Session:Dr Gro Harlem Brundtland, Director-General,
WHOSession Co-Chair
12:4513:30
- Press Conference and Launch of World TB Day 2000
- Concluding Session. "Forging New Partnerships to Stop TB"
- Co-Chaired by Dr Hussein GezairyRegional Director, EMRO, WHO and Dr Barbara
TurnerActing Deputy Director, USAID
13:30
Opening of Session
Dr Hussein Gezairy, Regional Director, EMRO, WHOSession Co-Chair
13:35-13:45
- "TuberculosisWomen and Children Can No Longer Wait" Mr
André Roberfroid, Deputy Executive Director, UNICEF
13:45-13:50
- "Forging New Partnerships to Stop TB"
Dr James Orbinski, International President, Médecins sans Frontières (MSF)
13:50-14:50
- Ministerial Panel"Partnerships for Action"
- Presentations: Congo DR, Indonesia, Nigeria followed by Plenary Discussion
14:50-15:05
- Concluding Address "Forging New Partnerships to Stop TB: A
Development Imperative", Dr Gro Harlem Brundtland, Director-General, WHO
15:05 Conference Adjourned
Acknowledgements
The organizers would like to thank Dr Els Borst-Eilers, Minister of Health, Welfare and
Sport, the Netherlands, and Ms Eveline Herfkens, Minister of Development Cooperation,
Ministry
of Foreign Affairs, the Netherlands, for co-hosting the Conference.
The expertise of His Excellency Korn Dabbaransi, Deputy Prime Minister and Minister of
Public Health, Thailand, in chairing the Amsterdam Declaration to Stop TB preparation and
adoption sessions is gratefully acknowledged.
The contribution of national delegations, government representatives and governmental
agencies, international organizations and others is appreciated.
The contribution in kind of the DIP Foundation is acknowledged.
The Conference was organized by the World Health Organization and the World Bank.
Thnaks to the Stop TB team for their valuable review and comments.
Project Manager: Heidi Larson
Writer: Lindsay Knight
Editor: Karen Reynolds
Designer: Anne Guilloux
Preface
Tuberculosis (TB) is a global public health emergency demanding concerted global action
to halt its rampage through some of the poorest countries in the world. High-ranking
participants at the Ministerial Conference in Amsterdam bore testimony to their collective
commitment to take actionand to take it NOW. Partners in the Stop TB Initiative and
the 20 highest TB burden countries represented at the Conference spoke eloquently of the
need for sustainable financing, resource mobilization and partnership building to overcome
this global threat and ward off its devastating social and economic consequences.
TB and Sustainable Developmentthe theme of the Conferenceencompassed its
aims: to place effective TB control high on the political agenda and to shift the emphasis
from a purely technical approach within the health sector to an intersectoral approach,
tackling TB from a sustainable development perspective. The grim statistics of TB are only
too well knowntwo million deaths and eight million new cases every year; the scourge
of the dual HIV/TB epidemic; and the spectre of multidrug-resistant TB (MDRTB). The
good news is also well knownthere is a cost-effective treatment strategy called DOTS
that has high cure rates. Currently, however, DOTS only reaches about 25% of TB patients,
which means there continue to be hundreds of thousands of preventable deaths every year.
The Conference gave delegates the opportunity to analyse country-specific challenges to
implementing effective global TB control. It brought together senior ministers from
various government sectors and donor agencies, providing an environment in which to
address issues of financing and sustainability. The terrible tragedies of TB were heard
through poignant personal testimonies and country presentations. But we also learned of
major gains through DOTS, of high cure rates and great optimism, given adequate levels of
funding and support for TB control.
The Amsterdam Declaration to Stop TB is a major cause for hope and optimism. Through
this Declaration, the 20 high-burden countries committed themselves to accelerated action
against TB and a strengthened Stop TB Initiative. We are inspired by this determination
and look forward to building on the momentum of the Conference and supporting the actions
outlined in the Declaration. We know that if we embrace our shared goals and vision we can
tackle this scourge. Together, we can Stop TB.
Dr Arata Kochi
Director the Stop TBInitiative
List of participants
DELEGATIONS FROM 20 TB HIGH BURDEN COUNTRIES
BANGLADESH
Mr Sheikh Fazlul Karim Selim, Minister of Health and Family Welfare, Ministry of Health
Professor A.B.M. Ahsan Ullah, Director General of Health Services, Directorate General of
Health
Mr Afzal Hossain, Deputy Secretary, Ministry of Health and Family Welfare
BRAZIL
Senator José Serra, Minister of Public Health Ministry of Health
Dr Gilberto Tanos Natalini, President of the National Council of Municipal Health
Secretaries, Ministério da Saúde
Dr Antonio Ruffino Netto, Technical Coordinator for Sanitary Pneumology, Ministry of
Health
CAMBODIA
H.E. Dr Hong Sun Huot, Minister of Health of the Kingdom of Cambodia, Ministry of Health
Dr Youk Sambath, Deputy Director for Finance and Budget, Ministry of Health
Dr Char Meng Chuor, Acting Director of Health Planning and Information, Ministry of Health
CHINA
Dr Wenkang Zhang, Minister of Health of the Peoples Republic of China, Ministry of
Health
Mr Qiang Gao, Vice-Minister of Finance of the Peoples Republic of China, Ministry of
Finance
Mr Peilong Liu, Director-General, Department of International Cooperation, Ministry of
Health
CONGO DR
Dr Bilenge Miaka Mia, Monsieur le Secrétaire général à la Santé publique, Ministère
de la Santé
ETHIOPIA
Dr Kebede Tadesse, Minister Social Sub-Sector, Prime Ministers Office
Dr Lamisso Hayesso, Vice-Minister of Health of the Federal Democratic Republic of
Ethiopia, Ministry of Health
Mr Ato Hailemelekot, T/Giorgis, Vice-Minister of Finance of the Federal Democratic
Republic
of Ethiopia
INDIA
Mr N.T. Shanmugam, Union Minister for Health, Ministry of Health and Family Welfare
Dr K. Venkatasubramaniun, Member (Health), Union Planning Commission
Dr Javid A. Chowdhury, Secretary (Health), Ministry of Health and Family Welfare
INDONESIA
H.E. Dr Achmad Sujudi, Minister of Health of the Republic of Indonesia, Ministry of Health
Mr Djunaedi Hadisumarto, Chairman of the National Development Planning Agency, Bappenas
Dr Umar Fahmi Achmadi, Acting Director-General of Communicable Disease Control and
Environmental Health, Ministry of Health
KENYA
Mr Sam K. Ongeri, Honourable Minister for Public Health, Ministry of Health
Mr Stephen Wainaina, Deputy Chief Economist, Ministry of Finance & Planning
Dr Richard Muga, Director of Medical Services, Ministry of Health
NIGERIA
Dr Tim Menakaya, Honourable Minister of Health, Federal Ministry of Health
Honourable Dr Willie E. Ogbeide, Chairman, House of Representative Committee on Health,
Federal Ministry of Health
Dr E. A. Abebe, Director, Primary Health Care and Disease Control, Federal Ministry of
Health
PAKISTAN
Dr Abdul Malik Kasi, Federal Health Minister, Ministry of Health
Maj. Gen. Ahsan Ahmed (Retd.), Director General (Health), Ministry of Health
Dr Mushtaq Ahmed Khan, Senior Chief Health Planning, Ministry of Planning and Development
PERU
Mr Arturo Arriniega, Netherlands Embassy of Peru
Mr Carlos Retes, Netherlands Embassy of Peru
PHILIPPINES
Honourable Alberto G. Romualdez, Secretary of Health, Department of Health
Honourable Felipe H. Medalla, Secretary of Socio-Economic Planning, National Economic
and Development Authority
Dr Juvencio F. Ordoña, Regional Director, Department of Health
RUSSIAN FEDERATION
Mr Yury Kalinin, Vice-Minister, Ministry of Justice of the Russian Federation
Dr Nikolay N. Fetisov, Director, Department of International Cooperation, Ministry of
Health
of the Russian Federation
Dr Sergei Furgal, Deputy Director, Department of International Cooperation, Ministry of
Health
of the Russian Federation
SOUTH AFRICA
Dr Manto Tshabalala-Msimang, Minister of Health, Department of Health
Dr Refiloe Matji, National TB Programme Manager, Department of Health
TANZANIA
Dr Aaron D Chiduo (MP), Minister of Health, Ministry of Health
Mr Nassoro W. Malocho (MP), Minister of State Presidents Office Planning
Dr Saidi M. Egwaga, NTLP Programme Manager, Ministry of Health
THAILAND
H.E. Korn Dabbaransi, Deputy Prime Minister, Minister of Public Health, Ministry of Public
Health
Dr Somsong Rugpoa, Director-General, Department of Communicable Disease Control
Dr Pasakorn Akarasewi, Director, Tuberculosis Division, DCDC
UGANDA
Dr Philip Byaruhanga, Honourable Minister of State for Health, (General Duties), Ministry
of Health
Professor Francis Omaswa, Director General of Health Services, Ministry of Health
Dr Ishmael Magana Mweru, Assistant Commissioner for Social Services, Ministry of Finance,
Planning and Economic Development
VIET NAM
Professor Ngoc Trong Le, Vice-Minister of Health, Ministry of Health
Mrs Thi Kim Ngan Nguyen, Vice-Minister of Finance, Ministry of Finance
Professor Viet Co Nguyen, Director, National Institute of TB & Respiratory Diseases
ZIMBABWE
Honourable Dr Timothy J. Stamps, Minister of Health and Child Welfare, Ministry of Health
and Child Welfare
Dr Paulinus Sikosana, Secretary for Health, Ministry of Health and Child Welfare
Dr Batsirai Makunike, Director Epidemiology and Disease Control, Ministry of Health and
Child Welfare
GOVERNMENT REPRESENTATIVES AND GOVERNMENTAL AGENCIES
Australia Australian Agency for International Development (AUSAID)
Belgium Cabinet of Development Cooperation
Canada Canadian International Development Agency (CIDA)
Finland Ministry for Foreign Affairs, Ministry of Social Affairs and Health
France Ministère de l'Emploi et de la Solidarité, Ministère des Affaires
étrangères
Germany Kreditanstalt Für Wiederaufbau (KFW), German Development Bank
Ireland Ministry of Foreign Affairs
Japan Ministry of Health and Welfare
Luxembourg Service National des Maladies Infectieuses, Ministre Plénipotentiaire
Netherlands Ministry of Health, Welfare and Sport Ministry of Foreign Affairs
* National Institute of Public Health and Environmental Protection (RIVM)
* Netherlands Embassy in Hanoi
* Netherlands Embassy of Dar es Salaam
Sweden Swedish International Development Cooperation Agency (SIDA)
UK Department for International Development
United States of America Department of Health and Human Services Centers for
Disease Control and Prevention (CDC)
* US Agency for International Development (USAID)
* US Department of State
ORGANIZATIONS
American Lung Association (ALA)
American Thoracic Society (ATS)
Gates Foundation
International Committee of the Red Cross (ICRC)
International Federation of the Red Cross and Red Crescent Societies (IFRC)
International Pediatric Association (IPA)
International Union Against Tuberculosis and Lung Disease (The Union)
Royal Tropical Institute (KIT)
Royal Netherlands Tuberculosis Association (KNCV)
Medical Committee Netherlands (MCN)
Médecins sans Frontières (MSF)
Open Society Institute (OSI)
Public Health Research Institute (PHRI)
Partners in Health (PIH)
Rockefeller Foundation
TB-NET
Joint United Nations Programme on HIV/AIDS (UNAIDS)
United Nations Childrens Fund (UNICEF)
World Health Organization (WHO)
World Bank
Opening Ceremony
Proceedings
The Conference opened with welcoming remarks from Dr Gro Harlem Brundtland,
Director-General of the World Health Organization (WHO) and Ms Eveline Herfkens, Minister
for Development Cooperation of the Netherlands. Both urged participants to capitalize on
the opportunity at hand.
Dr Brundtland
Some occasions provide unique opportunities for change. Such chances must be grasped
while they are there. If not, there may be years before the opportunity re-appears or it
may never happen again. This conference is such an opportunity for change. We must make
the most of it. We should take a moment to remind ourselves that we are sitting in the
very part of the world that was ravaged by tuberculosis in the 18th and 19th century. It
was a scourge that took whole families in its wave and left many others alone, as their
spouses, parents and siblings died of what was then known as "consumption".
Then, with the development of new TB drugs and improved living conditions due to
socio-economic development, TB disappeared in the lives and minds of many. We thought we
had conquered TBthat it would soon be a disease of the past. But, today we are faced
with a global epidemic that is killing more people than at any point in its history. This
week will be testimony to that. It will be a week to bring light to the gravity of this
persisting epidemic, as well as a time to chart our collective response
Minister Herfkens
The success of this conference depends on how political priorities are set in your
countries with regards to investments in human development and health.
TB control
cannot be seen as separate from a country's overall health policy. TB programmes will not
workor will be much less efficientin countries that lack a decent level of
basic health care. Their success depends strongly on the strength of the health care
system as a whole.I firmly believe that a sectoral approach will lead to more sustainable
TB programmes, with much better coverage.
I also believe that it will raise the overall standard of health care policies. I am
arguing against compartmentalization and for cohesion, so that TB programmes and the rest
of the health sector can benefit from one another. I sincerely hope that this conference
will strengthen the global partnership to stop TB.
Session 1- Improving Health:a Catalyst for Development
Session one confirmed the links between TB and development, ill-health and poverty, and
stressed how improved health is a catalyst for development.
TB affects the poorest people in the world95% of new TB cases every year are in
developing countriesand their illness tumbles them further into poverty. They are
unable to work when sick and families often have to sell what little they own to pay for
health care. Research by the World Bank among 60 000 poor people in 60 countries confirms
that one critical missing link between poverty and a life worth living is personal
security, especially freedom from disease. Illnesses such as TBand the deadly
combination of TB and HIV/AIDSprevent people from helping themselves out of poverty,
compounding the poverty cycle. Improved health through effective TB control contributes to
a countrys development.
TB control makes development sense
Delegates were urged to remember the lessons of TB control in the Netherlands and New
York City. In both places, as TB was brought under control, the facilities and resources
for treating the disease were scaled down. It was assumed TB could be consigned to the
history books. Instead, TB persisted.
In the Netherlands, the disease manifested itself again among poor communities such as the
homeless and among those with reduced resistance such as people with HIV. Today, TB
control is an integral part of the health care system in the Netherlands.
In New York City between 1979 and 1992, the number of patients with TB tripled and the
percentage of patients with MDR-TB more than doubled. By allocating the necessary
financial and human resources and designing a comprehensive, integrated TB control plan,
the City is winning the battle against TB. A crucial part of the programme is the use of
"Directly Observed Therapy", where outreach workers visit patients in their
homes and workplaces, in the streets, homeless shelters and subway stations. Today in New
York City, TB continues its downward trend.
The global response to TB has suffered from a legacy of complacency and neglect. There
has been no new TB drug for 30 years. There is no vaccine that truly protects against
infectious pulmonary disease. Investment is urgently needed in developing better
toolsdiagnostics, drugs, vaccinesto guarantee the elimination of TB for good.
Speakers stressed the urgency of the problem and the need to take action NOW to apply on a
large scale what is known about tackling the disease. Otherwise, the world faces the
growing threat of drug-resistant TB and a potentially incurable epidemic.
Credit: ©WHO/TDR/Crump
Conference speakers stress need for urgency: "We Must Act Now!" 6 Action
points
Dr Donna E. Shalala, Secretary of Health and Human Services, Department of Health and
Human Services, USA
1. Act now to avoid a more serious and dangerous epidemic in the future.
2. Make TB control programmes comprehensive and accountable: piecemeal approaches make
the problem worse.
3. Commit adequate resources, including the necessary political and social will.
4. Pledge commitment to research into new diagnostics, including a more rapid test for
MDR-TB, new drugs to reduce the length of treatment and a TB vaccine.
5. Eliminate the poor social and economic conditions that allow TB to survive and thrive.
6. Work together through global partnerships.
The Honourable Clare Short, Secretary of State for International Development, UK
"We can ensure this conference will be a turning point, by developing strategies
for sustainable financing, resource mobilization and partnership building. And when
weve all gone home, translating them into action. Action to tackle TB, action to
tackle poverty. We have the potential to consign TB to the dustbin of history. Lets
just do it."
Dr Els Borst-Eilers, Minister of Health, Welfare and Sport, The Netherlands
"The fight against tuberculosis is a dynamic process that needs to be adjusted
continuously. The moment you think you can sit back and relax, TB will rear its ugly head
again."
Dr Donna E. Shalala, Secretary of Health and Human Services, USA
"TB attacks the body and assaults the spirit. It hinders economic development. It
holds the poor in the grip of poverty and disease. And none of our nationsnorth or
south, east or westare immune from its threat."
Ms Mieko Nishimizu, Vice-President, The World Bank, USA
"Health expenditure to fight such epidemics will force very hard trade-offs in
public finance. Every time I look at such financial projections, I shudder. Economists
like me are not good at making impossible, unethical, trade-offs. I do not wish such
nightmares on anyone, especially political leaders of developing nations. But they will be
the reality one day if we do not act now."
Source for the four photographs: ©Capital Photos/WHO
Session 2: Confronting and Overcoming Challenges
Session two examined TB in the context of other infectious diseasesand learned
how Bangladesh, Kenya, the United Republic of Tanzania, and Viet Nam have successfully
confronted the epidemic and are overcoming particular challenges. All four countries have
committed considerable financial and human resources to TB control. Success is attributed
to political commitment and partnerships with NGOs, the private sector and international
agencies.
The importance of community education around TB and DOTS was stressed in discussion.
In South Africa, health officials go on community "focus weeks", materials on TB
are translated into local languages and there is a programme of campaigning and community
education.
Pakistan recognizes that community education needs in the country must be linked to one
phrasesocial stigma. Stigma is strongest in countries with the highest burden of TB
and is a major barrier to people seeking diagnosis.
TB in perspective
There are 54 million deaths in the world each year. In low-income nations, 45% of
deaths are due to infectious diseases, including TB. Worldwide, premature death from
infectious diseases is 48%, of which 90% is attributable to just six infectious diseases:
acute respiratory infections, TB, AIDS, diarrhoeal diseases, malaria, and measles. This
figure varies greatly from region to region. In the United States it is about 10%, whereas
in Sub-Saharan Africa it is as high as 60%. Partnerships between high-and low-prevalence
countries are crucial to addressing the TB epidemic.
TBand HIV/AIDS
HIV/AIDS has fuelled the rise in TB cases at an alarming rate, spawning a lethal dual
epidemic. Of the 2.3 million deaths from AIDS each year, one half million is due to TB.
AIDS is ravaging parts of Africa, leaving children orphaned and communities destitute. The
epidemic is rapidly becoming more devastating than war: it is now an international issue
of human security.
MDR-TB
Amajor challenge confronting TB control is the emergence of multidrug-resistant TB.
MDR-TB trends are alarming, and the cost of treating MDR-TB is 100 times more expensive
than standard TB treatment. Speakers recognized MDR-TB as a public health emergency
requiring a prompt international response, including research. It was noted that MDR-TBis
generated by poorly managed TBprogrammes. Several delegates spoke of the problem of
drug-resistant TB in their countries. In Tomsk in the Russian Federation, for example, 30%
of TB patients have MDR-TB. Globalization, particularly through international travel and
migration, contributes to the spread of TB and MDR-TB.
"In countries where strong political leadership, openness about the issues, strong
community involvement and broad, crosscutting responses come together, the tide is turning
and clear success is being demonstrated."
Dr Peter Piot, Executive Director, UNAIDS, Geneva - 3 messages
1. Any action that stops the HIV epidemic will also stop TB.
2. To stop TB we need to go beyond DOTS.
3. HIV and TB must not be competing prioritiespartnership is essential.
Ministerial Panel
Bangladesh
Bangladesh has achieved 90% DOTS coverage. Government is committed to addressing TB
through partnerships with the private sector, NGOs and international organizations such as
the World Bank. Challenges include expanding DOTS coverage to the main cities and to
remote populations, women and the poor.
Confronting the challenge of TB: Government and NGOs partners for DOTS
DOTSrapidly expanded
Streamlined resources
Capacity building
500 thanas
DOTSin 4 thanas
NGOs, Government
United Republic of Tanzania
The United Republic of Tanzania introduced DOTS as early as 1977. Cure rates of more
than 80% have been achieved, with low drug resistance. Strong Government commitment, close
collaboration with donors and integration of TB services have been key to its success.
Since 1982, the number of TB cases has increased four-fold due to HIV. This has led to an
overburdening of the health sector and has affected access to TB services. The challenge
is to scale up and sustain DOTS despite the severe impacts of the HIV/AIDS epidemic.
The Key to Success
Strong Government commitment
Collaboration with donors
Integration of NTP at service delivery point
Reliable drug-supply since 1983
Well-trained staff at all levels
Transport availability at all levels
Good recording, reporting and surveillance system
Strong technical supportnational and regional
Viet Nam
Viet Nam was the first Asian country to introduce a DOTS pilot programme in 1989. By
1997, DOTS was expanded nationwide (96%) and global targets of >70% detection rate and
>85% cure rate achieved. Strong political commitment, full integration of TB services
and strong international support has guaranteed success. Major challenges include the
growing threat of HIV/AIDS and the expansion of DOTS to remote and mountainous areas and
to vulnerable groups.
Reasons for Success
Strong political commitment
A vast and well-functioning health network
TBcontrol fully integrated
Nationwide implementation of DOTS
Effective and strong international support
Kenya
Kenya established a National TB and Leprosy Control Programme in 1980. TB services in
public institutions are free of charge. Government recognizes TB control as a public good.
These services are at risk, however, because of the rising TB epidemic in the last decade
due to HIV/AIDS: a 500% increase in TB case finding between 1987 and 1998. The highest
increase is among the most productive age group (15-49 years). Challenges include the
development of a joint HIV/AIDS-TB control strategy and further involvement of community
care providers.
Successes and Lessons Learned
Achieved national DOTS coverage
Quality services build users confidence
Coalition with AIDS programme to re-enforce control and prevention of HIV and TB
International support effectively used
Pro-active role in health sector reform
Partnerships developed since 20 years
Session 3: Taking Action
Session three focused
on opportunities for global action to Stop TB. Dr Arata Kochi, the Director of Stop TB,
proposed three initiatives to accelerate action to eliminate TB: the Global Investment
Plan, Global Drug Fund and Global Partnership Agreement. The draft Amsterdam Declaration
to Stop TB was presented for discussion and consideration by His Excellency Korn
Dabbaransi, Deputy Prime Minister and Minister of Public Health, Thailand.
The key issues raised in the discussion of the draft Declaration included the
reluctance of pharmaceutical companies to develop new TB drugs; a call for access to
low-cost drugs; the problem of poor countries having to pay for high cost MDR-TB
treatment; the inability of some countries to finance TB control due to indebtedness; and
the urgent need for vaccine development.
The role of effective TB control in strengthening health systems and contributing to
sustainable development was also highlighted, and the consequences of poor TB control were
addressed, particularly the risk of increasing drug resistance where TB programmes are
ineffective.
Expanding coverage of DOTS must involve changing the focus from a purely technical,
health intervention to a multisectoral response engaging the commitment of political
leaders and civil society.
A personal testimony
Ram Khadka, a teacher from Kathmandu, Nepal, gave a personal testimony to the misery of
TB.
TB killed both his parents. His mother developed MDR-TB after six years of ineffective TB
treatment. Mr Khadka became sick with TB whilst his mother was alive and started DOTS
treatment a month before her death. Mr Khadka reminded delegates that "although it is
not a recently emerging problem, we are still not able to eradicate this grand problem of
the world. History shows us that it took the lives of too many and it is growing even more
serious day to day because of HIV and MDR-TB." Mr Khadka called on governments around
the world to work together to eliminate TB or "soon the whole world will be a place
like hell and wont be a living place."
"The organizers, governments, NGOs and WHO who are working together to eradicate
TB have to involve people like us who had the bitter and hard experience of TB. The
involvement of technical manpower will not be the entire solution to the problem. There
needs to be a change in the attitude of people. They must know that TB can be cured. We
know it because we have had TB."
Mr Ram Khadka, Kathmandu, personal testimony
The mission of Stop TB
The mission of Stop TBis to ensure that every person with TB has all the necessary
information and access to treatment and cure; to protect vulnerable populations from TB
and multidrug-resistant TB; and to prevent the unnecessary social and economic tolls of
TB.
Opportunity for Action
Arata Kochi, Director, the Stop TB Initiative: "Why TB?"
Challenge
target
projections
accelerated progress
cases notified under DOTS in %
Strategy
Partnership
Technical approach
expanded to social and political
Health sector
Multi-sectoral approach
Massive burden of illness
Devastating social and economic impacts
Cost-effective strategy exists
Valuable catalyst for health development
TB control as international public good
Urgency due to HIV/AIDS and MDR-TB
Feasible even in resource-poor settings
Initiatives for Action
* Global Investment Plan
An investment guide to mobilize significant new resources and partners.
* Global Drug Facility
A mechanism to ensure equitable and reliable access to TB drugs for all who need them.
* Global Partnership Agreement
A means to operationalize the Amsterdam Declaration to Stop TB through expanded global and
national partnerships for action.
Session 4: Finance track
First round
Finance round tables in Session four debated the socioeconomic impacts of TB and
TB/HIV, and options for finance and sustainabilitysupported by country
presentations.
Socioeconomic impacts of TBand TB/HIV
India
India carries one-third of the global tuberculosis burden, which affects the most
productive age group (15-49 years). TB causes more deaths among women than all other
causes of maternal mortality in India. The social stigma associated with the disease makes
the situation worse. India recognizes that any TB control initiative has to be implemented
in tandem with poverty elimination programmes. In 1993, the Revised National TB Programme
based on the DOTS Strategy was started on a pilot basis and scaled up in 1997. Resources
were committed and free treatment is now available for a population of 130 million people.
Indonesia
Indonesia continues to suffer the economic legacy of poverty from the financial crisis
in Asia in 1997. In 1996, the World Bank estimated that TB caused 7.7% of the total
disease burden in the country. Approximately 75% of cases are in the economically active
age group of 1554 years. Some 60% of TB cases occur among the poor and poorly
educated. Indonesia introduced DOTS in 1990. The strategy aims for 70% coverage within
five years; currently, only about 51% of health clinics implement DOTS. Despite the
economic challenges, TB control is recognized as critical to avoid even more difficult and
expensive problems in the future.
Uganda
Uganda has experienced the dramatic socioeconomic impacts of the dual TB/HIV epidemic
for the past fifteen years. Half of TB patients are also infected with HIV. Life
expectancy has steadily declined since the onset of the HIV/AIDS epidemic. The
socioeconomic impacts of the dual epidemic on households and communities include:
Decreased labour supply;
Loss of skilled labour;
Increased number of orphans;
Loss of school time;
Loss of worktime leading to lower incomes and lower food production;
High financial costs to the family due to illness and burials;
Family livelihood disrupted and distress following death of the principal
wage-earner.
Zimbabwe
Zimbabwe has among the highest rates of HIV infection in the world. The TB and HIV
epidemics have together contributed to the decline in the average growth rate and the GDP
per capita. Debt servicing accounts for more than four times the expenditure on health and
education. Some 41% of the population lives on less than US$1 per day. Extended family
systems that used to care for orphans can no longer absorb the costs. Resources otherwise
available for investment are now used for health care and social welfare, especially care
for orphans. Where support for orphans is failing, the phenomenon of street children in
the major cities is rising. Life expectancy has declined by 17 years, principally among
the most socioeconomically active.
Additional country-specific information and indicators can be found in the Country
Profiles document (reference: WHO/CDS/STB/2000.3) prepared for the Conference or at www.stoptb.org.
Second round: Options for financing and sustainability
Democratic Republic of the Congo
Despite war, Congo DR has achieved 70% DOTS coverage. TB control is based in 306 health
centres around the country. Health centre personnel receive ongoing education. Partners in
this work include the Catholic Church. Major obstacles to TB control are debt servicing,
epidemics and war. Some 70% of financing comes from donors. The country recognizes the
need to mobilize partnerships across sectors and to obtain a constant and regular increase
of state budget earmarked for TB.
Pakistan
Pakistan has the fifth highest burden of TB in the world, causing approximately 26% of
all avoidable adult deaths. DOTS covers only 8% of TB patients. Pakistan is planning a
massive poverty alleviation programme. Improved literacy, especially among women, will
greatly contribute to the efficacy of the TB programme. The programme is based on two
guiding principles: self-reliance through regular budget sources and sustainability
through integration of programmes with general health services. Government is committed to
effective TB control and plans have been made for DOTS to expand nation-wide. All
provinces have allocated funds for TB in this financial year.
Philippines
The Philippines needs at least US$ 60 million over the next four years to reduce TB.
Anti-TB drugs are a major cost item. Although the NTP calls for free drugs for all
infectious cases, there have been insufficient resources to support this policy until
2000. A multi-year budget has now been proposed for TB until the year 2003. A planned
expansion of social health insurance is also under way. Currently, social health insurance
pays only for hospitalization of TB patients; however, the inclusion of outpatient TB
diagnostic and treatment services for poor people is being piloted. Efforts are being made
to lower drug costs and to reform the procurement system. Two major gaps in financing are
recognized: measures to address childhood TB and adequate provision for MDR-TB.
Russian Federation
Government has supported the fight against TB since 1910 by providing considerable
resources. Since 1992, however, there has been a significant rise in the incidence of TB,
with a major epidemic in the prisons. The increase is due mainly to the rapid
deterioration in social and economic conditions, including the flow of refugees. The
overall health system has severely deteriorated. Additional financial resources are needed
for the education of physicians and the general population, for monitoring TB incidence,
for the upgrading of diagnostic facilities and for anti-TB drugs.
Session 4: Health track
First round
Health round tables in Session four considered TB and health systems development, and
strategies to cope with the dual TB and TB/HIV epidemicssupported by country
presentations.
TB and Health Systems Development
Cambodia
Despite years of isolation and conflict, Cambodia introduced DOTS in 1994 and has
achieved 92% treatment success rates. Because of years of isolation and the resulting lack
of a health care infrastructure, TB services were implemented in a vertical manner. A
reform of the health sector aims at providing a network of health centres run by
multipurpose health workers. A pilot programme "DOTS in health centers" begun in
September 1999 integrates the already existing TB services. Health sector reform and the
integration of TB services have become even more important in the light of increasing HIV
rates which, in 1999, has led to a 14% increase of TB cases.
Viet Nam
Viet Nam has met WHO global targets for national DOTS coverage and TB cure rates. A
major contributing factor is the existing and well-functioning network of health services.
There is a health centre in every commune with dedicated and well-trained staff.
The active support of communities, mass organizations of women and peasants and peoples'
committees have been important factors in promoting DOTS. A World Bank loan as part of the
"Health Sector Support Project" has made possible the strengthening of commune
and district health centres including TB programmes in 19 provinces. Government is
committed to social equity in health care and provides basic services to the poor.
Challenges ahead include how to reach the minorities and underprivileged. Pilot projects
to develop community-based DOTS in mountainous and remote areas, and close collaboration
with the private sector and NGOs, will contribute to further improving health service
delivery and the countrys health system at large.
Ethiopia
Ethiopia's Health Sector Development Programme was launched five years ago and aims at
a comprehensive sector wide and integrated health system, focused on family health and
communicable disease prevention. The TB programme aims specifically at providing
management training for information systems to assure a continuous drug supply and
increased quality services such as microscopy, which Ethiopia recognizes are prerequisites
for a sustainable health system and effective TB control. The importance of Government
commitment and effective coordination within the Government as well as with donors and
partners is acknowledged. Challenges are maintaining the decentralization process while
coordinating and integrating activities.
Philippines
The present Philippines administration was elected on the basis of a pro-poor agenda,
which included an ambitious health sector reform agenda. A presidential memorandum signed
in 1998 made TB control a national priority. Public health reforms support the national TB
programme by improving the drug procurement system and ensuring prompt delivery of anti-TB
drugs to health centres. In 1991, legal autonomy was given to provinces, cities, and
municipalities. A devolved health delivery system makes local Government units critical to
DOTS implementation. It is expected that DOTS coverage will increase from 17% currently to
about 80% at the end of 2000. A key element for achieving targets is strong collaboration
with the private sector, particularly important as research shows that 80% of all TB
patients first see a private practitioner.
China
TB is the main communicable disease in China causing poverty in rural areas, and
hampering local economic development. There are at least 1.5 million new cases every year
and the total number of TB patients is 6 million. Government has used a World Bank loan
and domestic resources to introduce TB control through DOTS. In DOTS project areas, cure
rates are above 90%. Successful implementation relies heavily on the development of the
health system. DOTS implementation has significantly improved the functioning of the
health system and the technical skill and working capability of TB control workers.
Second round:Strategies to cope with the dual epidemic
South Africa
TB and HIV are of the highest priority in South Africa. The rapid progression of the
HIV epidemic has fuelled the already high numbers of TB cases. Socioeconomic diversity has
translated into an imbalance in service delivery across the country. In an attempt to
harmonize TB and HIV/AIDS control, key areas where both programmes could work together
have been identified:
Political commitment;
Multisectoral approach;
Guidance and support;
Research;
Monitoring and evaluation of current strategies.
Networks of community-based volunteers and lay assessors have been mobilized to provide
care for people living with HIV/AIDS and to ensure that TB treatment is accessible. To
improve collaboration between TB and HIV/AIDS programmes, pilot sites are being developed
in health education, voluntary counselling and testing, treatment of opportunistic
infections, care and support, and collaboration between home-based care projects and
community-based DOTS projects.
Thailand
It is estimated that HIV has contributed to 15%20% of the new TB cases in the
country after decades of decline in TB rates. In 1998, 20% of people infected with HIV
also had TB. As a result of HIV, TB affects more young people and debilitates more adults
in the productive age group than ever before. The dual epidemic has gone far beyond being
a health problem: it has destabilized families and impeded economic development.
Thailands response is to improve TB services at all levels, based on the DOTS
strategy, and to integrate TB care with HIV community-based care. Thailand is also drawing
from its experience with HIV/AIDS to address the dual epidemic. Government leadership, an
inter-sectoral response, education and information, and building networks with patient
groups and activists to prevent discrimination are among the strategies being used.
Uganda
The dual epidemic of TB/HIV is severe in Uganda with about 50% of TB cases being
HIV-positive. The national response is to mobilize all stakeholders, particularly
communities. The results are very promising with cure rates rising to 87%.
Decentralization, integration of TB and HIV/AIDS care into the general health system and
community involvement are key to a sustained TB programme. In the future, the
participation of communities will be extended to address malaria, immunisation, and
reproductive health. Village Health Committees will be set up in every village of 2000
people to mobilize a mass movement to promote health.
Zimbabwe
A key strategy in addressing the TB/HIV epidemics is the empowerment of communities to
get involved and take responsibility. A strategic change implemented in Zimbabwe is that
now the health services go to the patient. There is a policy of decentralization to the
district and the district health executive is the driver of the health services. The
Ministry of Finance now allows district communities to retain the fees collected for
health care.
Session 5: Investing in Health for the Long-Term
Session five considered financing and sustainability options as a means of investing in
health for the long-term.
Ms Mieko Nishimizu, the World Bank, reflected on the Conference and noted the
"wonderful learning" among delegates who shared common challenges and
experiences. The impressive collective strength and personal commitment of leaders was
commended. It was observed that such commonality stimulates a "virtuous cycle of
development partnership"a cycle that begins through action leading to visible
social and economic returns.
5 lessons
Ms Mieko Nishimizu, Vice-President, The World Bank, USA
1. In the fight against TBas in all other development challengesone size
does not fit all.
2. The enabling conditions of health systems and policies vary greatly among the 20
countries.
3. The financial constraints and associated strategies to create "room"
internally and externally in terms of resources differ.
4. Social and cultural contexts for effective health outcomes vary greatly.
5. The breadth and depth of political commitment is diverse.
10 recommendations
Dr William Foege, Senior Health Adviser, Bill and Melinda Gates Foundation, USA
1. We need to be globalistsnational boundaries must be forgotten.
2. Health and development are fused in a reciprocal relationshipno problem can be
understood in isolation.
3. Organize globally.
4. There is no single best approach.
5. The "secret" of leadership is in defining shared goals.
6. Money follows a good strategic plan. We need a plan that balances DOTS expansion and
MDR-TB containment.
7. Seize the moment. Every day opportunities are lost that cannot be reversed.
8. Make TB a political issue in every country. Public health decisions are ultimately
grounded in political decisions.
9. TB control is expensive, but not nearly as costly as the disease.
10. Take responsibility. Then provide the best management possible.
"Equity is the bottom line."
Ministerial panel: Financing and sustainability
"The difference between a body of scientific knowledge improving health or not
improving health comes down to management."
Dr William Foege, Bill and Melinda Gates Foundation, USA
Brazil
Brazil is committed to sustained TB control. Government spends approximately US$ 23
million a year on TB controlequal to a per capita spending of US$ 0.1330% more
than the level recommended by WHO. The new National Tuberculosis Programme established in
1998 focuses on integrating TB services into other major health initiatives and on
decentralization to bring decision-making and care closer to the patient. Challenges
include improving management capacities at local level and further improving the
laboratory network. Government has increased resources (such as for microscopes and drugs)
and DOTS is being expanded and implemented in all 27 States. To increase participation, a
bonus of between US$ 55 and U$ 85 is being paid to communities for each cured TB patient.
Brazil has committed resources to achieve cure rates of 85% by 2002.
China
In 1991, the World Bank and the Chinese Government jointly initiated a TB control
project. This, in addition to a special Government funded TB control project, reached a
total of 700 million people. More than 1.2 million infectious TB patients have now been
diagnosed and treated free of charge, with cure rates as high as 90%. TB is the main
communicable disease causing poverty. The Government is committed to expanding DOTS to 90%
of the population by 2005; it will increase the special budget for TB control and will
hold a national mobilization meeting.
India
Nearly 15% of the population is covered by DOTS compared with only 2% one year ago. It
is estimated that DOTS can prevent more than 1.5 million deaths by the year 2010the
largest number of lives saved for a single public health programme. India plans to
implement DOTS nationwide by 2005. Priority research areas are to develop an effective
vaccine and a new generation of drugs that require only one to two months of treatment.
The costs of TB control are currently borne disproportionately by developing countries.
The global community must increase its commitment to TB control, both in technical and
financial terms.
Nigeria
The budgetary allocation to health in Nigeria is low at only 2.0% to 2.5% of the
national budget. Currently, approximately 10% of TB patients are treated with support from
international donors. Government plans to provide treatment services to an additional 20%
in the year 2000, however, more resources are needed to address the TB problem nationwide.
In order to expand services further, the option of cost-sharing between three tiers of
Governmentfederal, state, and localis being considered. User charges have been
introduced in most health facilities, although TB treatment is free. In order to sustain
support for the TB programme, further cost-sharing with patients may be required. Other
options to mobilize finances are using the National Health Insurance System, linking with
the National AIDS and STI programme and reducing TB drug costs by centrally procuring them
in bulk. The establishment of a national Tuberculosis Fund with money raised from public
and private sectors has been discussed. In addition, decentralizing decision-making
processes as well as capacity building at a local level are envisaged in order to make
services more efficient.
Concluding session:"Forging New Partnerships to Stop TB"
Following unanimous adoption of the Amsterdam Declaration to Stop TB, the concluding
session heard statements from two of Stop TBs partners: UNICEF and Médecins sans
Frontières.
The case for UNICEFs involvement is clear. TB is a major threat to the rights of
the child, adolescents, and their families. The potential negative impact on the survival,
growth and development of its mandated populations is extremely grave. Women and young
people
(a rapidly growing affected group) face devastating stigmatization, which disenfranchises
the deeply affected and adds to the grave potential risks from inadequate treatment. The
impact on families is considerable. Evidence from the Asian Development Bank shows that at
least half of the financial crises in poor Asian families are triggered by a catastrophic
illness, especially TB.
Insufficient attention has been focused on the direct and indirect impact of TB in
children. The problem is underestimated because diagnosis is difficult. Children also
suffer the impacts of TB in families and are often taken out of schoolabout 300 000
a year in India. Children are inevitably neglected when parents fall sick. The disease
renders ineffective the taken-for-granted family coping mechanisms that have been the
foundation of community and family care systems for generations. UNICEF called for more
research on TB and HIV/AIDS that identifies the special risks to children in conflict
situations and to those who are refugees, trafficked, or are in conflict with the law.
UNICEF endorsed the need to expand DOTS and urged countries to establish National
Investment Plans to complement the Global Investment Plan being prepared by the Stop TB
partners. These plans must be multisectoral and involve a broad partnership reaching
beyond the health system. UNICEFalso called for more research on TBand children.
MEDECINS SANS FRONTIERES welcomed the fact that TB was now on the political agenda. For
too long it has been a technical, medical disease. Dr Orbinski, International President,
affirmed the need to improve, expand, and adapt DOTS. Accelerated research into new drugs,
diagnostics, vaccines, and different ways of using DOTS was called for. These solutions
rest on the right to health care for all, on the recognition of equity of access to health
care, and on the responsibility of governments and intergovernmental organizations to
ensure provision of health care.
Dr Orbinski noted that the 20 countries represented at the Conference did not have the
financial resources to fight TB alone or to invest in the research needed. Their capacity
was stretched to the limit. The market has clearly failed to produce new TB drugs. There
needs to be international leadership on drugs research. TB is a disease of the poor, but
the poor do not have consumer power. TB control is a public good and any public research
and development initiative into new TB drugs must put equity of access as its first goal;
access to the drug itself and to the intellectual property rights. A particular focus
should be on developing a drug that shortens DOTS treatment to less than three months with
minimal dosing requirements.
Ministerial PanelPartnerships for Action
5 action points
Dr Gro Harlem Brundtland, Director-General, WHO, Geneva
Let us
1. Make sure TB gets the priority it deserves in budget allocations.
2. Make sure that all people who need it can access treatment regardless of whether
they can pay for treatment.
3. Encourage the global community to back country partnerships to Stop TB and respond
positively to requests for support that benefits human development through tackling TB.
4. Work together in partnership fighting the global epidemic, helping people all over the
world to prevent TB.
5. Move urgently to tackle multidrug-resistant TB and continue to expand access to DOTS
while we can.
Democratic Republic of the Congo
For the past decade Government has had strong partnerships with NGOs working on TB
control. This has contributed to a very high number of cases being tracked and treated.
Challenges now are to improve the expertise of health workers, strengthen the coordination
capacity of the programme, prioritize advocacy and social mobilizationand end the
war.
Indonesia
Partnership is a key factor in the success of the National TB Programme. Every day, 500
people die from TBthe country has the third largest number of TB cases in the world.
The Gerdunas TB Movement launched by the Minister of Health in 1999 has mobilized
political commitment of the highest order. Long-term commitment from donors is essential
to ensure the continued success of the movement.
Nigeria
The National TB and Leprosy Control Programme launched in 1991 promotes the use of
DOTSimplemented in 19 of the 36 states. Many activities, such as the provision and
distribution of drugs, are carried out by a number of NGOs. In addition, joint action
plans have been developed with the National AIDS and STI Control Programme. In order to
ensure a continuous supply of drugs a key partner is the pharmaceutical industry. Other
sectors that play crucial roles in improving living standards, promoting health and
preventing TB are being targeted for collaboration, such as housing, education,
agriculture, labour and the community. In order to encourage more partnerships, the
Nigerian Government has set aside counter- part funds to support activities by development
partners who are willing to invest.
24 March: Launch of World TBDay
World TB Day
The theme "Forging new Partnerships to Stop TB" is a call to reach out beyond
the TB community and to mobilize new TB constituencies such as international agencies and
organizations, womens groups, human rights groups, HIV/AIDS groups, and others to
join the global movement to Stop TB.
Dr Gro Harlem Brundtland, Director-General, WHO
The theme of the Year 2000 World TB Day is "Forging New Partnerships to Stop
TB".
We have heard Ministers agree that no one should be denied access to
DOTS. This means that DOTS should be available to all who need it, wherever they
livewhether they are young or old, man or woman, homeless or housed, jailed or free.
We have heard Ministers agree that DOTS gives hope to people with HIV/AIDS. They too
should have access to DOTSwithout fear of stigma and discrimination.
We have heard Ministers stress the need for adequate funding to Stop TBwhether
from local government, central government or the international community.
We have heard Ministers describe how they have mobilized international resources, and
used them in ways that catalyzed a stronger national response to enable more people to
access TB treatment.
We have heard expression of commitment around the tableto a real increase in
global and national responses.
I now askHow can we best grasp the opportunity presented to us these past few
days? What will we do differently from tomorrow, after we leave this conference. How can
we all catalyze a difference in the lives of those suffering from TB and its devastating
impact?
As my colleague from the World Bank has reminded us, we will never realize
our dream of a world free of poverty "unless we join hands to overcome major global
threats to the poor and the marginalized". TB is such a threat, and we must, as the
World TB Day theme calls for, "Forge new partnerships to Stop TB".
UNAIDS PRESS RELEASE
Contact: Dominique DeSantis
Tel: (41) 22 791 4509
E-Mail: desantisd@unaids.org
UNAIDS SECRETARIAT JOINS "STOP TB INITIATIVE", STRESSES CLOSE LINKS BETWEEN
HIV AND TUBERCULOSIS
AMSTERDAM, 23 MARCH 2000. The secretariat of the Joint United Nations Programme on
HIV/AIDS (UNAIDS) has officially joined the Stop TB Initiative, a broad partnership to
halt the spread of tuberculosis around the world. The Initiative is hosted by the World
Health Organization, a Cosponsor of UNAIDS.
"There is still insufficient understanding of the close links between TB and
HIV," said Peter Piot, Executive Director of UNAIDS. "The two epidemics work
hand in hand. In some parts of Africa, their deadly synergy has quadrupled the number of
TB cases over the past ten years." Dr Piot was speaking on the eve of World TB Day at
the opening session of the Ministerial Conference on "Tuberculosis and Sustainable
Development" in Amsterdam.
"UNAIDS participation in the Stop TB Initiative is crucial in order to
effectively address the dual epidemic," said Dr Arata Kochi, Director of the Stop TB
Initiative.
The World Bank - News Release
News release No. 2000/254/HDContact: Christopher Walsh
Tel: 1 202 458 2710
E-Mail: Cwalsh@worldbank.org
TUBERCULOSIS POSES SERIOUS THREAT TO DEVELOPMENT
AMSTERDAM"The unity of purpose among the nations and agencies at this
conference is pathbreaking," said World Bank President James D. Wolfensohn. "We
know that only through partnerships can countries effectively respond to tuberculosis and
other top communicable disease threats. None of us can have the impact alone that we do
together."
UNICEF - Information
United Nations Children´s Fund
Fonds des Nations Unies pour l´enfanceCF/DOC/PR/200023
Fondo de las Naciones Unidas para la Infancia
Contact: Alfred Ironside
Tel: 1 212 326 7261
TUBERCULOSIS NOW A GLOBAL THREAT
UNICEF says support of worldwide DOTS system could stave off a catastrophe
Geneva/New York, 23 March 2000UNICEF today called tuberculosis "one of the
most seriously neglected and underestimated health, human rights and poverty problems of
our era" and said only a concerted effort could conquer a disease that accounts for
two million deaths a year, including over 250,000 children.
"TB is the globes leading infectious killer of youth and adults and a
leading killer of women," UNICEF Executive Director Carol Bellamy said. "In a
globalizing world, we need a quick, global solution." UNICEF Deputy Executive
Director André Roberfroid will underline the agency's concern in an address tomorrow to
the Ministerial Conference on TB and Sustainable Development, being held now in Amsterdam.
"The cost of inaction is high," Mr. Roberfroid says. "If we accept the
proliferation of inadequate TB treatment services and incorrect self-treatmenta real
possibility in Asiawe face a rise in the incidence of multidrug-resistant TB
(MDR-TB). That would be a humanitarian and epidemiological disaster."
World Health Organization (WHO)
PRESS Contact: Gregory Hartl
Tel: +(41) 22 791 4458
Press Release WHO/19www.who.int
DRUG-RESISTANT STRAINS OF TB INCREASING WORLDWIDE
New WHO report shows super-deadly TB strain is spreading. Drug resistant cases increase
by 50%
in parts of Western Europe. Countries to announce urgent control measures at ministerial
summit.
AmsterdamA new report released today by the World Health Organization and the
International Union Against TB and Lung Disease warns that if countries do not act quickly
to strengthen their control of TB, the multidrug-resistant strains that have cost New York
City and Russia hundreds of lives and more than US$1 billion each will continue to emerge
in other parts of the world.
In response, top government officials of 20 countries meeting today in Amsterdam are
expected to announce an ambitious strategy to "turn off the tap" of drug
resistance in the worst-affected countries. The focus of these efforts will be the
tripling of access over the next five years to a strategy proven to prevent MDR-TB from
developing.
Press Release WHO/20
WORLD TB DAY: PRESIDENT CLINTON HELPS TB PATIENTS
Action brings attention to India's success in treating TB
United States President Bill Clinton marked World Tuberculosis Day by administering the
World Health Organization (WHO)-recommended DOTS treatment to TB patients in Hyderabad,
India. At the Mahavir Hospital outpatient facility, President Clinton participated in the
cure of three TB patients, who received their final dose of medicine of a six-month
treatment, under the DOTS programme, today. One patient was an 18 year-old woman, the
second a 35 year-old rickshaw driver. President Clinton himself administered the dose of
three pills to a 12 year-old girl and then signed the TB register documenting her cure.
© World Health Organization, 2000
This document is not issued to the general public, and all rights are reserved by the
World Health Organization (WHO). The document may not be reviewed, abstracted, quoted,
reproduced or translated, in whole or in part, without the prior written permission of
WHO. No part of this document may be stored in a retrieval system or transmitted in any
form or by any meanselectronic, mechanical or otherwithout the prior written
permission of WHO.
The designations employed and the presentation of the material in this work do not
imply the expression of any opinion whatsoever on the part of WHO concerning the legal
status of any country, territory, city or area or of its authorities, or concerning the
delimitation of its frontiers and boundaries.
The mention of specific companies or of certain manufacturers products does not imply
that they are endorsed or recommended by WHO in preference to others of a similar nature
that are not mentionned. Errors and omissions excepted, the names of proprietary products
are distinguished by initial capital letters.
This report contains the collective views of an international group of experts, and
does not necessarily represent the decisions or the stated policy of WHO. The full text of
speeches can be found at www.stoptb.org.
For further information please contact:
The Stop TB Initiative
World Health Organization
20, avenue Appia
1211 Geneva 27Switzerland
Tel. +(41) 22 791 2675
Fax +(41) 22 791 4199
http://www.who.int
|